Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
C3-Southern Illinois University Carbondale refers to a specific experimental intervention arm (Condition 3) in a clinical study titled "Effects of the Interaction of Caffeine and Hydration on Voice Performance." This intervention involves the oral administration of a 200 mg caffeine tablet in combination with 1 liter of water. Developed by researchers at Southern Illinois University Carbondale, the protocol is designed to evaluate whether high-volume systemic hydration can mitigate the potential degradation of vocal performance caused by caffeine ingestion. Caffeine primarily acts as a non-selective antagonist of adenosine receptors (A1 and A2A), which can lead to increased alertness but also potential dehydration of the vocal fold mucosa; the water component is intended to maintain hydration.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on caffeine + water (Southern Illinois University Carbondale).